Lesser Poland Cracovian Heart Failure Registry

What this Trial Is About

Researchers are conducting the Lesser Poland Cracovian Heart Failure Registry (LECRA-HF) to improve understanding of acute heart failure (AHF) and its long-term outcomes. The study aims to assess the prognosis of AHF and its influencing factors, identify optimal treatment approaches, evaluate the role of invasive coronary diagnostics and revascularization, and analyze specific heart failure subtypes, including HFimpEF, HFpEF, HFsnEF, HFrEF, and HFmrEF. This registry addresses the need for more reliable data on this diverse patient population, particularly within the Polish context. The LECRA-HF registry includes patients hospitalized with acute heart failure who are over 18 years old. Participants are categorized into three groups based on left ventricular ejection fraction (LVEF) according to European Society of Cardiology guidelines: reduced (LVEF ≤40%), mildly reduced (LVEF 41-49%), and preserved (LVEF ≥50%) ejection fraction. The registry is continuous and will be updated annually until 2026 to capture comprehensive data. During the study, detailed clinical information will be collected, including medical history, physical measurements, electrocardiograms, imaging, laboratory tests, and treatments during hospitalization and after discharge. Researchers will analyze the long-term prognosis, including all-cause mortality, cardiovascular mortality, and heart failure rehospitalizations over two years. This thorough data collection supports better characterization of heart failure subtypes and informs future treatment strategies.

Lesser Poland Cracovian Heart Failure Registry